Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
US8865212B2 · kind B2 · utility
6Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2006 |
| Grant date | Oct 21, 2014 |
| Priority date | — |
| Expiry date | Jan 25, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosed invention provides oral pharmaceutical formulations of an acid labile benzimidazole derivative comprising (a) a core comprising an acid labile benzimidazole derivative, (b) a seal coating layer, and (c) an enteric coating layer, wherein the core of the composition is devoid of any disintegrant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.